Overview
Announcements

Ordinary Adjustment | Solactive Genomics v2 Index | Effective Date 17th November 2025

Solactive Genomics v2 Index:

In the ordinary adjustment, the following composition will be implemented effective open 17th November 2025:

10X GENOMICS INC
AGILENT TECHNOLOGIES INC
ALNYLAM PHARMACEUTICALS INC
ARCTURUS THERAPEUTICS HOLDINGS INC
ARROWHEAD PHARMACEUTICALS INC
ASTRAZENECA PLC
AVIDITY BIOSCIENCES INC
BEAM THERAPEUTICS INC
BIO-TECHNE CORP
BIOMARIN PHARMACEUTICAL INC
BIONTECH SE
BRISTOL-MYERS SQUIBB CO
CAREDX INC
CARIBOU BIOSCIENCES INC
CRISPR THERAPEUTICS AG
CUREVAC BV
EDITAS MEDICINE INC
ELI LILLY & CO
FULGENT GENETICS INC
GENEDX HOLDINGS CORP
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
GUARDANT HEALTH INC
ILLUMINA INC
INTELLIA THERAPEUTICS INC
LEGEND BIOTECH CORP
MARAVAI LIFESCIENCES HOLDINGS INC
MESA LABORATORIES INC
MODERNA INC
MYRIAD GENETICS INC
NATERA INC
PACIFIC BIOSCIENCES OF CALIFORNIA INC
PERSONALIS INC
PRIME MEDICINE INC
Praxis Precision Medicines Inc
QIAGEN NV
REGENXBIO INC
ROCKET PHARMACEUTICALS INC
SANA BIOTECHNOLOGY INC
SANGAMO THERAPEUTICS INC
SAREPTA THERAPEUTICS INC
STANDARD BIOTOOLS INC
STOKE THERAPEUTICS INC
TWIST BIOSCIENCE CORP
ULTRAGENYX PHARMACEUTICAL INC
UNIQURE B.V.
VERACYTE INC
VERTEX PHARMACEUTICALS INC
VIR BIOTECHNOLOGY INC
WAVE LIFE SCIENCES PTE LTD